Depressive Disorder Clinical Trial
Official title:
Effectiveness of a Brief Psychological Mindfulness Based Intervention for the Treatment of Depression in Primary Care: Face-to-face Application, Treatment as Usual and Application Through ICTs
Verified date | March 2020 |
Source | Universitat Jaume I |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to assess and compare a mindfulness low-intensity (4 weeks) psychological intervention for the treatment of depression in Primary Care between different groups: a mindfulness intervention applied face to face in group format, a control group that will receive treatment as usual (TAU) consisting of medical treatment and the same mindfulness intervention applied by Information and Communication Technologies (ICTs). The principal hypothesis is that face to face intervention will be more effective than TAU
Status | Active, not recruiting |
Enrollment | 120 |
Est. completion date | June 2020 |
Est. primary completion date | June 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: - Be adult - Willingness to participate in the study and signing informed consent - Ability to understand and write Spanish. - DSM-5 diagnose of Major Depression or Dysthymia, mild or moderate depression expressed as score lower than 14 in the Patient Health Questionnaire (PHQ) - Duration of depressive symptoms 2 months or more - To have and to handle the computer and internet Exclusion Criteria: - Any diagnose of disease that may affect central nervous system (brain pathology, traumatic brain injury, dementia, etc.), - Other psychiatric diagnoses or acute psychiatric illness (substance dependence or abuse, history of schizophrenia or other psychotic disorders, eating disorders, etc.), except for anxious pathology or personality disorders - Any medical, infectious or degenerative disease that may affect mood, presence of delusional ideas or hallucinations consistent or not with mood, and suicide risk |
Country | Name | City | State |
---|---|---|---|
Spain | Universitat Jaume I | Castellon de la Plana | Valencia |
Lead Sponsor | Collaborator |
---|---|
Universitat Jaume I | Research Unit in Primary Care of Aragon (Spain) |
Spain,
Andersson G, Titov N. Advantages and limitations of Internet-based interventions for common mental disorders. World Psychiatry. 2014 Feb;13(1):4-11. doi: 10.1002/wps.20083. — View Citation
Backenstrass M, Joest K, Frank A, Hingmann S, Mundt C, Kronmüller KT. Preferences for treatment in primary care: a comparison of nondepressive, subsyndromal and major depressive patients. Gen Hosp Psychiatry. 2006 Mar-Apr;28(2):178-80. Erratum in: Gen Hosp Psychiatry. 2006 May-Jun;28(3):266. — View Citation
Cuijpers P, van Straten A, van Schaik A, Andersson G. Psychological treatment of depression in primary care: a meta-analysis. Br J Gen Pract. 2009 Feb;59(559):e51-60. doi: 10.3399/bjgp09X395139. — View Citation
Kuyken W, Byford S, Taylor RS, Watkins E, Holden E, White K, Barrett B, Byng R, Evans A, Mullan E, Teasdale JD. Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol. 2008 Dec;76(6):966-78. doi: 10.1037/a0013786. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Client Service Receipt Inventory (CSRI) | This inventory includes the number of times health services have been used.Collect the sick leave, the number of hospital admissions, the number of times that the person attends an emergency service, number of times that is attended by a healthcare professional and finally collects the medication. There is no maximum or minimum score, it simply provides information. | Baseline | |
Other | Client Service Receipt Inventory (CSRI) | This inventory includes the number of times health services have been used.Collect the sick leave, the number of hospital admissions, the number of times that the person attends an emergency service, number of times that is attended by a healthcare professional and finally collects the medication. There is no maximum or minimum score, it simply provides information. | Six-months follow-up | |
Other | Client Service Receipt Inventory (CSRI) | This inventory includes the number of times health services have been used.Collect the sick leave, the number of hospital admissions, the number of times that the person attends an emergency service, number of times that is attended by a healthcare professional and finally collects the medication. There is no maximum or minimum score, it simply provides information. | Twelve-months follow-up | |
Primary | Beck Depression Inventory-II | Baseline | ||
Primary | Beck Depression Inventory-II | In the mindfulness-based intervention applied by ICTs | Post-treatment 8 weeks from baseline in 8 weeks intervention group | |
Primary | Beck Depression Inventory-II | In the mindfulness-based intervention applied face-to-face and TAU group | post-treatment 4 weeks from baseline in 4 weeks intervention group | |
Primary | Beck Depression Inventory-II | Six-months follow-up | ||
Primary | Beck Depression Inventory-II | Twelve-months follow-up | ||
Secondary | Sociodemographic data Gender, age, marital status, education, occupation, economical level | Baseline | ||
Secondary | Health Survey 12 (SF-12) | Baseline | ||
Secondary | Health Survey 12 (SF-12) | In the mindfulness-based intervention applied by ICTs | Post-treatment 8 weeks from baseline in 8 weeks intervention group | |
Secondary | Health Survey 12 (SF-12) | In the mindfulness-based intervention applied face-to-face and TAU group | Post-treatment 4 weeks from baseline in 4 weeks intervention group | |
Secondary | Health Survey 12 (SF-12) | Six-months follow-up | ||
Secondary | Health Survey 12 (SF-12) | Twelve-months follow-up | ||
Secondary | EuroQol (EQ-5D). Health related quality of life | Baseline | ||
Secondary | EuroQol (EQ-5D). Health related quality of life | Six-months follow-up | ||
Secondary | EuroQol (EQ-5D). Health related quality of life | Twelve-months follow-up | ||
Secondary | Positive and negative affect (PANAS) | Baseline | ||
Secondary | Positive and negative affect (PANAS) | In the mindfulness-based intervention applied by ICTs | Post-treatment 8 weeks from baseline in 8 weeks intervention group | |
Secondary | Positive and negative affect (PANAS) | In the mindfulness-based intervention applied face-to-face and TAU group | Post-treatment 4 weeks from baseline in 4 weeks intervention group | |
Secondary | Positive and negative affect (PANAS) | Six-months follow-up | ||
Secondary | Positive and negative affect (PANAS) | Twelve-months follow-up | ||
Secondary | Five Facets and factors of mindfulness (FFMQ) | Baseline | ||
Secondary | Five Facets and factors of mindfulness (FFMQ) | Six-months follow-up | ||
Secondary | Five Facets and factors of mindfulness (FFMQ) | Twelve-months follow-up | ||
Secondary | Pemberton Happiness Index (PHI) | Baseline | ||
Secondary | Pemberton Happiness Index (PHI) | Six-months follow-up | ||
Secondary | Pemberton Happiness Index (PHI) | Twelve-months follow-up | ||
Secondary | Patient Health Questionnaire-9 | Baseline | ||
Secondary | Patient Health Questionnaire-9 | In the mindfulness-based intervention applied by ICTs | Post-treatment 8 weeks from baseline in 8 weeks intervention group | |
Secondary | Patient Health Questionnaire-9 | In the mindfulness-based intervention applied face-to-face and TAU group | Post-treatment 4 weeks from baseline in 4 weeks intervention group | |
Secondary | Patient Health Questionnaire-9 | Six-months follow-up | ||
Secondary | Patient Health Questionnaire-9 | twelve-months follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01316926 -
Paxil CR Bioequivalence Study Brazil
|
Phase 1 | |
Recruiting |
NCT06187454 -
Transcranial Direct Current Stimulation for Depression
|
N/A | |
Completed |
NCT04469322 -
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
|
N/A | |
Recruiting |
NCT05768126 -
Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
|
Phase 4 | |
Completed |
NCT03219879 -
Telephone-administered Relapse Prevention for Depression
|
N/A | |
Recruiting |
NCT06038721 -
Unified Protocol: Community Connections
|
N/A | |
Completed |
NCT03043560 -
Study to Treat Major Depressive Disorder With a New Medication
|
Phase 2 | |
Completed |
NCT04091139 -
Research of Unified Protocol for the Treatment of Common Mental Disorders in Adolescents in Hong Kong
|
Phase 2/Phase 3 | |
Completed |
NCT00069459 -
Seasonal Affective Depression (SAD) Study
|
Phase 1 | |
Recruiting |
NCT05503966 -
Combining Antidepressants and Attention Bias Modification in Depression
|
N/A | |
Recruiting |
NCT03001245 -
Interpersonal Counseling (IPC) for Treatment of Depression in Adolescents
|
N/A | |
Completed |
NCT02939560 -
TMS for Adults With Autism and Depression
|
N/A | |
Completed |
NCT02452892 -
Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
|
N/A | |
Completed |
NCT02542891 -
European Comparative Effectiveness Research on Internet-based Depression Treatment
|
N/A | |
Completed |
NCT02306551 -
Well Being And Resilience: Mechanisms of Transmission of Health and Risk
|
||
Withdrawn |
NCT02238730 -
Ultrabrief Right Unilateral and Brief Pulse Bitemporal Electroconvulsive Therapy
|
N/A | |
Completed |
NCT02224508 -
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
|
N/A | |
Completed |
NCT01597661 -
Bupropion & Cardio Birth Defect (Slone)
|
N/A | |
Completed |
NCT01407575 -
Buprenorphine for Treatment Resistant Depression
|
Phase 3 | |
Completed |
NCT01093053 -
Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations
|
N/A |